Status:

WITHDRAWN

Home-Based Covid-19 Rehabilitation Program

Lead Sponsor:

Albert Einstein College of Medicine

Conditions:

Covid-19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Our aim is to conduct a pilot single-blind randomized controlled trial to examine the preliminary efficacy of a 14 day app-based pulmonary and mobility focused rehabilitation program (intervention arm...

Detailed Description

As of April 20, 2020, there had been over 2.4 million confirmed cases of coronavirus disease 2019 (COVID-19) reported globally; 759,786 cases in USA. Triage protocols have been developed to prioritize...

Eligibility Criteria

Inclusion

  • Age 18 and older.
  • Symptoms suggestive of Covid-19 infection (fever, cough, chest discomfort or loss of smell/taste).
  • Covid-19 screening done.
  • Ambulatory without assistive devices (such as cane or walker).
  • Access to PT-Pal app via cellular phone, iPad or computer (e.g. Zoom™).

Exclusion

  • Severe symptoms requiring referral to the Emergency Department.
  • Contraindications to exercise (cardiac disease such as diagnosed arrhythmias, on home oxygen, or end stage organ failure).
  • Known history of poorly controlled diabetes or hypertension.
  • Active neurological or psychiatric illnesses.

Key Trial Info

Start Date :

May 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04406532

Start Date

May 1 2021

End Date

March 1 2022

Last Update

May 4 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.